IL2 and neoplasm: In Treg-replete (phosphate-buffered saline-injected) or Treg-depleted (DT injected) tumor-bearing (day 12) DEREG mice, 1:1 mixture of congenic IL-2(CD45.1) and IL-7(CD45.2) effectors was intratumorally injected.